SeaStar Medical Holding Corporation (ICU)
NASDAQ·Healthcare·Biotechnology
$3.97
+4.07%
Mkt Cap $7.36M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 25, 2026 | $222.50K | $420.00K | +88.76% | -$0.97 | -$0.80 | +17.53% | — | — |
| Q4 2025 Nov 13, 2025 | $250.00K | $183.00K | -26.80% | -$1.50 | -$1.30 | +13.33% | — | — |
| Q3 2025 Aug 13, 2025 | $245.00K | $338.00K | +37.96% | -$0.43 | -$0.18 | +58.14% | — | — |
| Q2 2025 May 14, 2025 | $150.00K | $293.00K | +95.33% | -$0.52 | -$0.44 | +15.38% | — | — |
| Q1 2025 Mar 27, 2025 | $150.00K | $67.00K | -55.33% | -$0.89 | -$0.90 | -1.12% | — | — |
| Q4 2024 Nov 13, 2024 | $150.00K | $68.00K | -54.67% | -$1.13 | -$1.10 | +2.65% | — | — |
| Q3 2024 Aug 13, 2024 | $100.00K | — | — | -$1.41 | -$1.03 | +26.95% | — | — |
| Q2 2024 May 14, 2024 | $150.00K | — | — | -$0.15 | -$4.75 | -3066.67% | — | — |
| Q1 2024 Mar 13, 2024 | $175.00K | — | — | -$0.13 | -$0.22 | -69.23% | — | — |
| Q4 2023 Nov 14, 2023 | $50.00K | — | — | -$0.25 | -$3.00 | -1100.00% | — | — |
| Q3 2023 Aug 14, 2023 | $50.00K | — | — | -$0.25 | -$6.25 | -2400.00% | — | — |
| Q2 2023 May 15, 2023 | — | — | — | -$5.00 | -$10.00 | -100.00% | — | — |
| Q1 2023 Mar 30, 2023 | — | — | — | — | -$160.97 | — | — | — |
| Q3 2022 Sep 30, 2022 | — | — | — | — | -$36.29 | — | — | — |
| Q3 2022 Aug 16, 2022 | — | — | — | — | -$17.30 | — | — | — |
| Q1 2022 Mar 31, 2022 | — | — | — | — | -$19.26 | — | — | — |
| Q4 2021 Dec 31, 2021 | — | — | — | — | -$23.35 | — | — | — |
| Q3 2021 Sep 30, 2021 | — | — | — | — | -$23.14 | — | — | — |
| Q2 2021 Jun 30, 2021 | — | — | — | — | -$21.77 | — | — | — |
| Q1 2021 Mar 31, 2021 | — | — | — | — | -$20.42 | — | — | — |